FDA concedes SOBI’s IND application for SOBI003 along with Fast Track Status for treating MPS IIIA Read more
CHMP of EMA conveyed negative trend vote of Puma’s MA for neratinib for treating HER2-positive Breast Cancer Read more
Cerus affirms positive results for Phase 3 transfusion study assessing INTERCEPT RBC’s in Thalassemia patients Read more
Astellas Pharma and Vical asserts negative Phase 3 Clinical Trial results for ASP0113 for CMV-HSCT recipients Read more
Agenus launches its Clinical Trial combination of its anti-CTLA4 (AGEN1884) and anti-PD1 (AGEN2034) antibodies Read more
AstraZeneca and Merck asserted the approval of LYNPARZA tablets for patients with Ovarian Cancer Read more
OncoSec Medical proclaims preliminary clinical observations of OMS-1140 Clinical Trial of ImmunoPulse in TNBC patients Read more